U.S. markets open in 4 hours 7 minutes
  • S&P Futures

    3,852.75
    +43.50 (+1.14%)
     
  • Dow Futures

    31,231.00
    +319.00 (+1.03%)
     
  • Nasdaq Futures

    13,109.75
    +198.75 (+1.54%)
     
  • Russell 2000 Futures

    2,248.00
    +48.80 (+2.22%)
     
  • Crude Oil

    62.39
    +0.89 (+1.45%)
     
  • Gold

    1,744.10
    +15.30 (+0.89%)
     
  • Silver

    26.91
    +0.47 (+1.76%)
     
  • EUR/USD

    1.2045
    -0.0042 (-0.35%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    25.05
    -3.84 (-13.29%)
     
  • GBP/USD

    1.3953
    +0.0030 (+0.22%)
     
  • USD/JPY

    106.6900
    +0.1880 (+0.18%)
     
  • BTC-USD

    47,339.79
    +1,888.54 (+4.16%)
     
  • CMC Crypto 200

    951.17
    +18.03 (+1.93%)
     
  • FTSE 100

    6,592.91
    +109.48 (+1.69%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the SVB Leerink Global Healthcare Conference on Wednesday, Feb. 24, 2021 at 9:20 a.m. ET (2:20 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-svb-leerink-10th-annual-global-healthcare-conference-301231128.html

SOURCE Alkermes plc